Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation.

Carron C, Pais de Barros JP, Gaiffe E, Deckert V, Adda-Rezig H, Roubiou C, Laheurte C, Masson D, Simula-Faivre D, Louvat P, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Saas P, Ducloux D, Lagrost L, Bamoulid J.

Front Immunol. 2019 Aug 16;10:1630. doi: 10.3389/fimmu.2019.01630. eCollection 2019.

2.

Improved quantification of plasma lipopolysaccharide (LPS) burden in sepsis using 3-hydroxy myristate (3HM): a cohort study.

Dargent A, Pais De Barros JP, Ksiazek E, Fournel I, Dusuel A, Rerole AL, Choubley H, Masson D, Lagrost L, Quenot JP.

Intensive Care Med. 2019 Nov;45(11):1678-1680. doi: 10.1007/s00134-019-05749-0. Epub 2019 Aug 26. No abstract available.

PMID:
31451860
3.

Polysaccharide Chain Length of Lipopolysaccharides From Salmonella Minnesota Is a Determinant of Aggregate Stability, Plasma Residence Time and Proinflammatory Propensity in vivo.

Sali W, Patoli D, Pais de Barros JP, Labbé J, Deckert V, Duhéron V, Le Guern N, Blache D, Chaumont D, Lesniewska E, Gasquet B, Paul C, Moreau M, Denat F, Masson D, Lagrost L, Gautier T.

Front Microbiol. 2019 Aug 2;10:1774. doi: 10.3389/fmicb.2019.01774. eCollection 2019.

4.

Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis.

Jalil A, Bourgeois T, Ménégaut L, Lagrost L, Thomas C, Masson D.

Int J Mol Sci. 2019 Aug 2;20(15). pii: E3787. doi: 10.3390/ijms20153787. Review.

5.

Healthy adiposity and extended lifespan in obese mice fed a diet supplemented with a polyphenol-rich plant extract.

Aires V, Labbé J, Deckert V, Pais de Barros JP, Boidot R, Haumont M, Maquart G, Le Guern N, Masson D, Prost-Camus E, Prost M, Lagrost L.

Sci Rep. 2019 Jun 24;9(1):9134. doi: 10.1038/s41598-019-45600-6.

6.

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia.

Li L, Foo BJW, Kwok KW, Sakamoto N, Mukae H, Izumikawa K, Mandard S, Quenot JP, Lagrost L, Teh WK, Singh Kohli G, Zhu P, Choi H, Buist ML, Seet JE, Yang L, He F, Kwong Chow VT, Tan NS.

MBio. 2019 Jun 4;10(3). pii: e02469-18. doi: 10.1128/mBio.02469-18.

7.

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration but not with visceral fat and liver fat content in people with type 1 diabetes.

Bouillet B, Gautier T, Rouland A, Duvillard L, Petit JM, Lagrost L, Vergès B.

Acta Diabetol. 2019 Oct;56(10):1155-1157. doi: 10.1007/s00592-019-01367-w. Epub 2019 May 22. No abstract available.

PMID:
31119457
8.

CETP activity is not associated with carotid intima-media thickness in patients with poorly controlled type 2 diabetes.

Bouillet B, Gautier T, Terriat B, Lagrost L, Verges B, Petit JM.

Acta Diabetol. 2019 Jul;56(7):749-754. doi: 10.1007/s00592-019-01340-7. Epub 2019 Apr 12.

PMID:
30980187
9.

Brain Vitamin E Deficiency During Development Is Associated With Increased Glutamate Levels and Anxiety in Adult Mice.

Desrumaux CM, Mansuy M, Lemaire S, Przybilski J, Le Guern N, Givalois L, Lagrost L.

Front Behav Neurosci. 2018 Dec 11;12:310. doi: 10.3389/fnbeh.2018.00310. eCollection 2018.

10.

Erratum. The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. Diabetes 2018;67:1512-1523.

Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, Bouchot A, Dardevet D, Morio-Liondor B, Cani PD, Lagrost L, Narce M, Bellenger J.

Diabetes. 2019 Jan;68(1):235. doi: 10.2337/db19-er01a. Epub 2018 Nov 19. No abstract available.

11.

A chronic LPS-induced low-grade inflammation fails to reproduce in lean mice the impairment of preference for oily solution found in diet-induced obese mice.

Bernard A, Ancel D, Passilly-Degrace P, Landrier JF, Lagrost L, Besnard P.

Biochimie. 2019 Apr;159:112-121. doi: 10.1016/j.biochi.2018.08.004. Epub 2018 Aug 10.

12.

Author Correction: Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids.

Besnard P, Christensen JE, Brignot H, Bernard A, Passilly-Degrace P, Nicklaus S, Pais de Barros JP, Collet X, Lelouvier B, Servant F, Blasco-Baque V, Verges B, Lagrost L, Feron G, Burcelin R.

Sci Rep. 2018 Jun 22;8(1):9773. doi: 10.1038/s41598-018-27701-w.

13.

Circulating levels of 3-hydroxymyristate, a direct quantification of endotoxaemia in noninfected cirrhotic patients.

Weil D, Pais de Barros JP, Mourey G, Laheurte C, Cypriani B, Badet N, Delabrousse E, Grandclément E, Di Martino V, Saas P, Lagrost L, Thévenot T.

Liver Int. 2019 Jan;39(1):106-114. doi: 10.1111/liv.13916. Epub 2018 Jul 30.

PMID:
29931819
14.

LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.

Thomas C, Jalil A, Magnani C, Ishibashi M, Queré R, Bourgeois T, Bergas V, Ménégaut L, Patoli D, Le Guern N, Labbé J, Gautier T, de Barros JPP, Lagrost L, Masson D.

Atherosclerosis. 2018 Aug;275:409-418. doi: 10.1016/j.atherosclerosis.2018.05.023. Epub 2018 May 18.

PMID:
29866392
15.

The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders.

Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, Bouchot A, Dardevet D, Morio B, Cani PD, Lagrost L, Narce M, Bellenger J.

Diabetes. 2018 Aug;67(8):1512-1523. doi: 10.2337/db17-1488. Epub 2018 May 23. Erratum in: Diabetes. 2019 Jan;68(1):235.

16.

Plasma phospholipid transfer protein (PLTP) as an emerging determinant of the adaptive immune response.

Desrumaux C, Lagrost L.

Cell Mol Immunol. 2018 Dec;15(12):1077-1079. doi: 10.1038/s41423-018-0036-9. Epub 2018 May 7. No abstract available.

17.

Deletion of plasma Phospholipid Transfer Protein (PLTP) increases microglial phagocytosis and reduces cerebral amyloid-β deposition in the J20 mouse model of Alzheimer's disease.

Mansuy M, Baille S, Canet G, Borie A, Cohen-Solal C, Vignes M, Perrier V, Chevallier N, Le Guern N, Deckert V, Lagrost L, Givalois L, Desrumaux C.

Oncotarget. 2018 Apr 13;9(28):19688-19703. doi: 10.18632/oncotarget.24802. eCollection 2018 Apr 13.

18.

Obese Subjects With Specific Gustatory Papillae Microbiota and Salivary Cues Display an Impairment to Sense Lipids.

Besnard P, Christensen JE, Brignot H, Bernard A, Passilly-Degrace P, Nicklaus S, Pais de Barros JP, Collet X, Lelouvier B, Servant F, Blasco-Baque V, Verges B, Lagrost L, Feron G, Burcelin R.

Sci Rep. 2018 Apr 30;8(1):6742. doi: 10.1038/s41598-018-24619-1. Erratum in: Sci Rep. 2018 Jun 22;8(1):9773.

19.

PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.

Audo R, Deckert V, Daien CI, Che H, Elhmioui J, Lemaire S, Pais de Barros JP, Desrumaux C, Combe B, Hahne M, Lagrost L, Morel J.

PLoS One. 2018 Mar 22;13(3):e0193815. doi: 10.1371/journal.pone.0193815. eCollection 2018.

20.

Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion.

Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, Thomas C, Bourgeois T, Dejong CHC, Kox M, Hundscheid IHR, Khan NA, Mandard S, Deckert V, Pickkers P, Drucker DJ, Lagrost L, Grober J.

Cell Rep. 2017 Oct 31;21(5):1160-1168. doi: 10.1016/j.celrep.2017.10.008.

21.

Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?

Daguindau E, Gautier T, Chagué C, Pais de Barros JP, Deckert V, Lagrost L, Saas P.

Front Immunol. 2017 Aug 9;8:952. doi: 10.3389/fimmu.2017.00952. eCollection 2017. No abstract available.

22.

Plasma cholesterol level determines in vivo prion propagation.

Perrier V, Imberdis T, Lafon PA, Cefis M, Wang Y, Huetter E, Arnaud JD, Alvarez-Martinez T, Le Guern N, Maquart G, Lagrost L, Desrumaux C.

J Lipid Res. 2017 Oct;58(10):1950-1961. doi: 10.1194/jlr.M073718. Epub 2017 Aug 1.

23.

Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.

Deckert V, Lemaire S, Ripoll PJ, de Barros JP, Labbé J, Borgne CC, Turquois V, Maquart G, Larose D, Desroche N, Ménétrier F, Le Guern N, Lebrun LJ, Desrumaux C, Gautier T, Grober J, Thomas C, Masson D, Houdebine LM, Lagrost L.

Sci Rep. 2017 Jun 8;7(1):3053. doi: 10.1038/s41598-017-03285-9.

24.

Brain Control of Plasma Cholesterol Involves Polysialic Acid Molecules in the Hypothalamus.

Brenachot X, Gautier T, Nédélec E, Deckert V, Laderrière A, Nuzzaci D, Rigault C, Lemoine A, Pénicaud L, Lagrost L, Benani A.

Front Neurosci. 2017 May 3;11:245. doi: 10.3389/fnins.2017.00245. eCollection 2017.

25.

Fatty acid metabolism in macrophages: a target in cardio-metabolic diseases.

Ménégaut L, Thomas C, Lagrost L, Masson D.

Curr Opin Lipidol. 2017 Feb;28(1):19-26. doi: 10.1097/MOL.0000000000000370. Review.

PMID:
27870652
26.

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.

Ceroi A, Masson D, Roggy A, Roumier C, Chagué C, Gauthier T, Philippe L, Lamarthée B, Angelot-Delettre F, Bonnefoy F, Perruche S, Biichle S, Preudhomme C, Macintyre E, Lagrost L, Garnache-Ottou F, Saas P.

Blood. 2016 Dec 8;128(23):2694-2707. Epub 2016 Oct 4.

27.

Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.

Ménégaut L, Masson D, Abello N, Denimal D, Truntzer C, Ducoroy P, Lagrost L, Pais de Barros JP, Athias A, Petit JM, Martin L, Steinmetz E, Kretz B.

Atherosclerosis. 2016 Aug;251:339-347. doi: 10.1016/j.atherosclerosis.2016.05.004. Epub 2016 May 4.

PMID:
27189320
28.

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration, but not visceral fat, in patients with type 2 diabetes.

Bouillet B, Gautier T, Aho LS, Duvillard L, Petit JM, Lagrost L, Vergès B.

Diabetes Metab. 2016 Sep;42(4):263-6. doi: 10.1016/j.diabet.2016.01.003. Epub 2016 Feb 28.

PMID:
26934823
29.

The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation.

Ceroi A, Delettre FA, Marotel C, Gauthier T, Asgarova A, Biichlé S, Duperrier A, Mourey G, Perruche S, Lagrost L, Masson D, Saas P.

Haematologica. 2016 Mar;101(3):e72-6. doi: 10.3324/haematol.2015.135459. Epub 2015 Dec 3. No abstract available.

30.

Very high volume hemofiltration with the Cascade system in septic shock patients.

Quenot JP, Binquet C, Vinsonneau C, Barbar SD, Vinault S, Deckert V, Lemaire S, Hassain AA, Bruyère R, Souweine B, Lagrost L, Adrie C.

Intensive Care Med. 2015 Dec;41(12):2111-20. doi: 10.1007/s00134-015-4056-y. Epub 2015 Oct 2.

PMID:
26431720
31.

Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome.

Limoge F, Faivre L, Gautier T, Petit JM, Gautier E, Masson D, Jego G, El Chehadeh-Djebbar S, Marle N, Carmignac V, Deckert V, Brindisi MC, Edery P, Ghoumid J, Blair E, Lagrost L, Thauvin-Robinet C, Duplomb L.

Hum Mol Genet. 2015 Dec 1;24(23):6603-13. doi: 10.1093/hmg/ddv366. Epub 2015 Sep 10.

PMID:
26358774
32.

Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.

Desrumaux C, Lemaire-Ewing S, Ogier N, Yessoufou A, Hammann A, Sequeira-Le Grand A, Deckert V, Pais de Barros JP, Le Guern N, Guy J, Khan NA, Lagrost L.

Cell Mol Immunol. 2016 Nov;13(6):795-804. doi: 10.1038/cmi.2015.75. Epub 2015 Aug 31.

33.

The potential of cholesteryl ester transfer protein as a therapeutic target.

Gautier T, Masson D, Lagrost L.

Expert Opin Ther Targets. 2016;20(1):47-59. doi: 10.1517/14728222.2015.1073713. Epub 2015 Jul 27. Review.

PMID:
26212254
34.

Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay.

Pais de Barros JP, Gautier T, Sali W, Adrie C, Choubley H, Charron E, Lalande C, Le Guern N, Deckert V, Monchi M, Quenot JP, Lagrost L.

J Lipid Res. 2015 Jul;56(7):1363-9. doi: 10.1194/jlr.D059725. Epub 2015 May 28.

35.

Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis.

Varin A, Thomas C, Ishibashi M, Ménégaut L, Gautier T, Trousson A, Bergas V, de Barros JP, Narce M, Lobaccaro JM, Lagrost L, Masson D.

Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1357-65. doi: 10.1161/ATVBAHA.115.305539. Epub 2015 Apr 2.

PMID:
25838428
36.

The authors reply.

Lagrost L, Girard C, Masson D, Bonithon-Kopp C.

Crit Care Med. 2014 Oct;42(10):e686-7. doi: 10.1097/CCM.0000000000000580. No abstract available.

PMID:
25226151
37.

Induction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbits.

Jolivet G, Braud S, DaSilva B, Passet B, Harscoët E, Viglietta C, Gautier T, Lagrost L, Daniel-Carlier N, Houdebine LM, Harosh I.

PLoS One. 2014 Sep 12;9(9):e106655. doi: 10.1371/journal.pone.0106655. eCollection 2014.

38.

Glycated albumin with loss of fatty acid binding capacity contributes to enhanced arachidonate oxygenation and platelet hyperactivity: relevance in patients with type 2 diabetes.

Blache D, Bourdon E, Salloignon P, Lucchi G, Ducoroy P, Petit JM, Verges B, Lagrost L.

Diabetes. 2015 Mar;64(3):960-72. doi: 10.2337/db14-0879. Epub 2014 Aug 25.

39.

Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins.

Vergès B, Duvillard L, Lagrost L, Vachoux C, Garret C, Bouyer K, Courtney M, Pomié C, Burcelin R.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1245-53. doi: 10.1210/jc.2013-3463. Epub 2014 Apr 2.

PMID:
24694333
40.

Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes.

Bouillet B, Gautier T, Blache D, Pais de Barros JP, Duvillard L, Petit JM, Lagrost L, Vergès B.

Diabetes Care. 2014 Apr;37(4):1148-56. doi: 10.2337/dc13-1467. Epub 2014 Feb 26.

PMID:
24574346
41.

Low preoperative cholesterol level is a risk factor of sepsis and poor clinical outcome in patients undergoing cardiac surgery with cardiopulmonary bypass.

Lagrost L, Girard C, Grosjean S, Masson D, Deckert V, Gautier T, Debomy F, Vinault S, Jeannin A, Labbé J, Bonithon-Kopp C.

Crit Care Med. 2014 May;42(5):1065-73. doi: 10.1097/CCM.0000000000000165.

PMID:
24413578
42.

Dual labeling of lipopolysaccharides for SPECT-CT imaging and fluorescence microscopy.

Duheron V, Moreau M, Collin B, Sali W, Bernhard C, Goze C, Gautier T, Pais de Barros JP, Deckert V, Brunotte F, Lagrost L, Denat F.

ACS Chem Biol. 2014 Mar 21;9(3):656-62. doi: 10.1021/cb400779j. Epub 2013 Dec 20.

PMID:
24328371
43.

Disturbances in cholesterol, bile acid and glucose metabolism in peroxisomal 3-ketoacylCoA thiolase B deficient mice fed diets containing high or low fat contents.

Nicolas-Francès V, Arnauld S, Kaminski J, Ver Loren van Themaat E, Clémencet MC, Chamouton J, Athias A, Grober J, Gresti J, Degrace P, Lagrost L, Latruffe N, Mandard S.

Biochimie. 2014 Mar;98:86-101. doi: 10.1016/j.biochi.2013.11.014. Epub 2013 Nov 26.

44.

Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway.

Nguyen AT, Mandard S, Dray C, Deckert V, Valet P, Besnard P, Drucker DJ, Lagrost L, Grober J.

Diabetes. 2014 Feb;63(2):471-82. doi: 10.2337/db13-0903. Epub 2013 Nov 1.

45.

Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice.

Zou Z, Bellenger S, Massey KA, Nicolaou A, Geissler A, Bidu C, Bonnotte B, Pierre AS, Minville-Walz M, Rialland M, Seubert J, Kang JX, Lagrost L, Narce M, Bellenger J.

J Lipid Res. 2013 Dec;54(12):3453-63. doi: 10.1194/jlr.M042754. Epub 2013 Sep 19.

46.

Development of abdominal aortic aneurysm is decreased in mice with plasma phospholipid transfer protein deficiency.

Deckert V, Kretz B, Habbout A, Raghay K, Labbé J, Abello N, Desrumaux C, Gautier T, Lemaire-Ewing S, Maquart G, Le Guern N, Masson D, Steinmetz E, Lagrost L.

Am J Pathol. 2013 Sep;183(3):975-86. doi: 10.1016/j.ajpath.2013.05.018. Epub 2013 Jul 2.

PMID:
23830874
47.

Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice.

Gautier T, de Haan W, Grober J, Ye D, Bahr MJ, Claudel T, Nijstad N, Van Berkel TJ, Havekes LM, Manns MP, Willems SM, Hogendoorn PC, Lagrost L, Kuipers F, Van Eck M, Rensen PC, Tietge UJ.

J Lipid Res. 2013 Aug;54(8):2195-205. doi: 10.1194/jlr.M038141. Epub 2013 Apr 25.

48.

Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.

Ishibashi M, Varin A, Filomenko R, Lopez T, Athias A, Gambert P, Blache D, Thomas C, Gautier T, Lagrost L, Masson D.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1171-9. doi: 10.1161/ATVBAHA.112.300812. Epub 2013 Apr 11.

PMID:
23580142
49.

Plasma PCSK9 is a late biomarker of severity in patients with severe trauma injury.

Le Bras M, Roquilly A, Deckert V, Langhi C, Feuillet F, Sébille V, Mahé PJ, Bach K, Masson D, Lagrost L, Costet P, Asehnoune K, Cariou B.

J Clin Endocrinol Metab. 2013 Apr;98(4):E732-6. doi: 10.1210/jc.2012-4236. Epub 2013 Feb 28.

PMID:
23450051
50.

Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.

Ishibashi M, Filomenko R, Rébé C, Chevriaux A, Varin A, Derangère V, Bessède G, Gambert P, Lagrost L, Masson D.

Biochem Pharmacol. 2013 Jul 1;86(1):122-9. doi: 10.1016/j.bcp.2012.12.024. Epub 2013 Jan 9.

PMID:
23313547

Supplemental Content

Loading ...
Support Center